AIROS Medical
Private Company
Total funding raised: $15.2M
Overview
AIROS Medical is a private, commercial-stage medical device company focused on the large and growing market for compression therapy. Founded by Durable Medical Equipment (DME) industry veterans, the company leverages deep clinical and reimbursement expertise to develop and commercialize pneumatic compression pumps and garments. Its core AIROS 6 and AIROS 8 systems treat lymphatic and venous conditions, with a recent strategic expansion into the arterial disease segment via the FDA-cleared ARTAIRA device. The company appears to be in a revenue-generating phase, selling through DME suppliers and directly to patients/therapists.
Technology Platform
Pneumatic compression therapy platform featuring programmable, multi-chamber sequential gradient pumps (including peristaltic modes) and a suite of specialized garments for lymphatic/venous drainage and, separately, high-pressure intermittent compression for arterial blood flow augmentation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
AIROS competes in the pneumatic compression therapy market against companies like Tactile Medical (lymphedema pumps), Bio Compression Systems, and Lympha Press. Its expansion into PAD with ARTAIRA places it against other arterial assist devices and broader PAD treatment modalities, including pharmaceuticals and surgical interventions.